Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-23
2000-10-17
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514579, 514647, A61K 3113, A61K 31135, A61K 314748
Patent
active
06133281&
ABSTRACT:
Methods are presented for the treatment of benign prostatic hyperplasia. The methods provide for administration to a person at least one compound identified generically as antagonists of N-methyl-D-aspartate receptors. These compounds are selected from the group consisting of memantidine, amantidine, dextromethorphan and ketamine.
REFERENCES:
patent: 5162311 (1992-11-01), Herrling et al.
Achari R, Laddu A (1993) Terazosin: A New Alpha Adrenoceptor Blocking Drug. J. Clin Pharmacol 32:520-523.
Albers GW, et al., (1995) Safety, Tolerability and Pharmacokinetics of the N-Methyl-D-Aspartate Antagonist Ro-01-6794/706 in Patients with Acute Ischemic Stroke. Annals NY Academy of Sciences :250-261.
Bessho Y, et al., (1993) Glutamate receptor agonists enhance the expression of BDNF mRNA in cultured cerebellar granule cells. Brain Res Mol Brain Res 18:201-208.
Bourguignon JP, et al., (1993) Control of pulsatile secretion of gonadotrophin releasing hormone from hypothalamic explants. Human Reproduction 2:18-22.
Brann DW, et al., (1993) Steroid Hormone Effects on NMDA Receptor Binding and NMDA Receptor mRNA Levels in the Hypothalamus and Cerebral Cortex of the Adult Rat. Neuroendocrinology 58:666-672.
Catalona WJ (1994) Management of Cancer of the Prostate. New England Journal of Medicine 331:996-1004.
Dehpour AR, et al., (1995) Different Calcium Dependencies of Contractile Activity of Prostatic and Epididymal Portions of Rat Vas Deferens. Gen. Pharmac. 26:633-639.
D'Ercole AJ, et al., (1994) Tissue concentrations of somatomedin C: Further evidence for mlutiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935-939.
Doble, A (1995) Excitatory amino acid receptors and neurodegeneration. Therapie 50:319-337.
Fallon, B (1995) Intracavernous Injection Therapy for Male Erectile Dysfunction. Urologic Clinics of North America 22:883-845.
Feldman HA, et al., (1994) Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study. The Journal of Urology 151:54-61.
Garban H, et al., (1995) Restoration of Normal Adult Penile Erectile Response in Aged Rats by Long-Term Treatment with Androgens. Biology of Reproduction 53:1365-1372.
Garban H, et al., (1995) Effect of aging on nitric oxide-mediated penile erection in rats. American Journal of Physiology 268:H467-H475.
Garban H, et al., (1997) Cloning of Rat and Human Inducible Penile Nitric Oxide Synthase. Application for Gene Therapy of Erectile Dysfunction. Biology of Reproduction 56:954-963.
Giorda C, et al., (1995) Alpha-1 Blocker Doxazosin Improves Peripheral Insulin Sensitivity in Diabetic Hypertensive Patients. Metabolism 44:673-676.
Grimwood S, et al., (1996) Generation and Characterisation of Stable Cell Lines Expressing Recombinant Human N-Methyl-D-Aspartate Receptor Subtypes. Journal of Neurochemistry 66:2239-2247.
Guh J-H, et al., (1995) Characterization of Alpha-1 adrenoceptor subtypes in tension response of human prostate to electrical field stimulation. J Pharmacol 115:142-146.
Hung A, et al., (1995) Expression of Inducible Nitric Oxide Synthase in Smooth Muscle Cells From Rat Penile Corpora Cavernosa. J Androl 16:469-481.
Ishii T, et al., (1993) Molecular Characterization of the Family of the N-Methl-D-Aspartate Receptor Subunits. The Journal of Biological Chemistry 268:2836-2843.
Janknegt RA, et al., (1993) Efficacy and Safety of the Alpha-1 Blocker Doxazosin in the Treatment of Benign Prostatic Hyperplasia. Eur Urol 24:319-326.
Kornhuber J, et al., (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm 43:91-104.
Kyncl JJ (1993) Pharmacology of Terazosin: An Alpha-1 Selective Blocker. J Clin Pharmacol 33:866-899.
Lee T-S, Hou X (1995) Vasoactive Effects of Ketamine on Isolated Rabbit Pulmonary Arteries. Chest 107:1152-1155.
Lepor H, et al., (1996) The Efficacy of Terazosin, Finasteride, or both in Benign Prostatic Hyperplasia. New England Journal of Medicine 335:533-539.
Levsin (hyoscyamine sulfate USP) (1997). Physician's Desk Reference, pp. 2405-2406.
Linet OI, et al., (1996) Efficacy and safety of intracavernosal Alprostad; 1 in men with erectile dysfunction. New England Journal of Medicine 334:873-877.
Lugg JA, et al., (1995) Dihydrotestosterone is the Active Androgen in the Maintenance of Nitric Oxide-Mediated Penile Erection in the Rat. Endocrinology 136:1495-1501.
Lugg JA, et al., (1996) Cavernosal nerve stimulation in the rat reverses castration-induced decrease in penile NOS activity. Am J Physiol 34:354-361.
Magee T, et al., (1996) Cloning of a Novel Neuronal Nitric Oxide Synthase Expressed in Penis and Lower Urinary Tract. Biochemical and Biophysical Research Communications 226:141-151.
Matsumoto G, et al., (1995) Role of glutamate and NMDA receptors in the descencing limb of the spinobulbospinal micturition reflex pathway of the rat. Neuroscience Letters 183:58-61.
McCann SM (1997) The Nitric Oxide Hypothesis of Brain Aging. Experimental Gerontology 32:431-440.
Munir H, et al., (1996) Pharmacological and Immunological Characterization of N-methyl-D-aspartate Receptors in HumN Nt2-N Neurons. Journal of Pharmacology and Experimental Therapeutics 276:819-828.
Murray F, et al., (1995) Evaluation and Treatment of Erectile Dysfunction. American Journal of the Medicial Sciences 309:99-109.
Osterling JE (1995) Benign Prostatic Hyperplasia. Medical and Minimally Invasive Treatment Options. Drug Therapy 332:99-109.
Osterling JE, et al., (1994) A new reality for urology: Drugs that alleviate BPH symptoms. Contemporary Urology 6:2-10.
Penson DF, et al., (1996) Androgen and Pituitary Control of Penile Nitric Oxide Synthase and Erectile Function in the Rat. Biology of Reproduction 55: 567-574.
Persson K, et al., (1992) Effects of inhibition in the L-arginine
itric oxide pathway in the rat lower urinary tract in vivo and in vitro. Br I Pharmacol 107:178-184.
Pedersen CM, et al., (1993) Smooth muscle relaxant effects of propofol and ketamine in isolated guinea-pig trachea. European Journal of Pharmacology 238:75-80.
Penson DF, et al., (1997) Adrenal Control of Erectile Function and Nitric Oxide Synthase in the Rat Penis. Endocrinology, 138(9), 1-8.
Rajfer J, et al., (1992) Nitric Oxide as a Mediator or Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission. New England Journal of Medicine 326:90-94.
Said SI, (1995) N-Methyl-D-Aspartate Receptors Outside The Central Nervous System: Activation Causes Acute Lung Injury That is Mediated by Nitric Oxide Synthesis and Prevented by Vasoactive Intestinal Peptide. Neuroscience 65:943-946.
Saito M, et al., (1994) Effect of Partial Outflow Obstruction on Rat Detrusor Contractility and Intracellular Free Calcium Concentration. Neurourology and Urodynamics 13:297-305.
Saito M, et al., (1993) Effects of Partial Outlet Obstruction of the Rat Urinary Bladder on Micturition Characteristics, DNA Synthesis and the Contractile Response to Field Stimulation and Pharmacological Agents. The Journal of Urology 150:1045-1051.
Saito M, et al., (1993) Effect of Partial Outlet Obstruction on Contractility: Comparison Between Severe and Mild Obstruction. Neurourology and Urodynamics 12:573-583.
Steers WD (1993) Physiology of the Urinary Bladder. In Campbells Urology, pp. 142-176.
Sugihara H, et al., (1992) Structures and Properties of Seven Isoforms of the NMDA Receptor Generated by Alternative Splicing. Biochemical and Biophysical Research Communications 185:862-832.
Szabo L, et al., (1993) Voiding Disorders and Unstable Bladder in Children. International Urology and Nephrology 25:431-437.
Takeda M, et al., (1994) Effects of Nitric Oxide on Human and Canine Prostates. Adult Urology 45:440-446.
Testa S, et al., (1996) Functional Antagonistic Activity of REC 15/2739, a Novel Alpha-1 Antagonist Selective for
Thomas RJ (1995) Excitatory Amino Acids in Health and Disease. J Am Geriatr Soc 43:1279-1289.
Thornberg SA, et al., (1996) A Review of NMDA Receptors and the Phencyclidine Model of Schizophrenia. Pharmacotherapy 16:82-93.
Tortella FC,
Gonzalez-Cadavid Nestor F.
Rajfer Jacob A.
Harbor-UCLA Research and Education Institute
Spivack Phyllis G.
LandOfFree
NMDA receptor blockers in the therapy of urogenital disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NMDA receptor blockers in the therapy of urogenital disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NMDA receptor blockers in the therapy of urogenital disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-469280